Studies have shown that drug resistant tumor cells are highly dependent on Gln utilization, with glutamate dehydrogenase 1 (GLUD1) serving as a key factor in Gln addiction in acquired drug-resistant NSCLC cells. The gene discussed is GLUD1; the disease is neoplasm.